Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 457-463

  Hudson, David L ^a   Speight, Paul M ^b   Watt, Fiona M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V5 ANTIGEN; CD44V6 ANTIGEN; INVOLUCRIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ALTERNATIVE SPLICING; ANTIGENS, CD44; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINOCYTES; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; MOUTH NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029974248     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<457::AID-IJC8>3.0.CO;2-V     Document Type: Article

References (32)

1. BARTOLAZZI, A., JACKSON, D., BENNETT, K., ARUFFO, A., DICKINSON, R., SHIELDS, J., WHITTLE, N. and STAMENKOVIC, I., Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J. Cell Sci., 108, 1723-1733 (1995).
2. BENNETT, K.L., JACKSON, D.G., SIMON, J.C., TANCZOS, E., PEACH, R., MODRELL, B., STAMENKOVIC, I., PLOWMAN, G. and ARUFFO, A., CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol., 128, 687-698 (1995).
3. BIRCH, M., MITCHELL, S. and HART, I.R., Isolation and characterization of human-melanoma cell variants expressing high and low-levels of CD44. Cancer Res., 51, 6660-6667 (1991).
4. BRAGA, V.M.M., PEMBERTON, L.F., DUHIG, T. and GENDLER, S.J., Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development. Development, 115, 427-437 (1992).
5. BROWN, T.A., BOUCHARD, T., ST. JOHN, T., WAYNER, E. and CARTER, W.G., Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol., 113, 207-221 (1991).
6. COMBARET, V., LASSET, C., FRAPPAZ, D., BOUVIER, R., THIESSE, P., REBILLARD, A.-C, PHILIP, T. and FAVROT, M.C., Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors. Europ. J. Cancer, 31A, 545-549 (1995).
7. DALL, P., HEIDER, K.-H., SINN, H.-P., SKROCH-ANGEL, P., ADOLF, G., KAUFMANN, M., HERRLICH, P. and PONTA, H., Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int. J. Cancer, 60, 471-477 (1995).
8. FAWCETT, J., HOLNESS, C.L. and SIMMONS, D.L., Molecular tools for the analysis of cell adhesion. Cell Adhesion Comm., 2, 275-285 (1994).
9. FOX, S.B., FAWCETT, J., JACKSON, D.G., COLLINS, I., GATTER, K.C., HARRIS, A.L., GEARING, A. and SIMMONS, D.L., Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res., 54, 4539-4546 (1994).
10. GÜNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZÖLLER, M., HAUSSMANN, I., MATZKU, S., WENZEL, A., PONTA, H. and HERRLICH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24 (1991).
11. HILL, M.W., Cell renewal in oral epithelia. In: J. Meyer, C.A. Squier, and S.J. Gerson (eds.), The structure and function of oral mucosa, pp. 53-81, Pergamon Press, Oxford (1980).
12. HUDSON, D.L., SLEEMAN, J. and WATT, F.M., CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J. Cell Sci., 108, 1959-1970 (1995).
13. ISACKE, C.M., SAUVAGE, C.A., HYMAN, R., LESLEY, J., SCHULTE, R. and TROWBRIDGE, I.S., Identification and characterisation of the human Pgp-1 glycoprotein. Immunogenetics, 23, 326-332 (1986).
14. ISACKE, C.M., VAN DER GERR, P., HUNTER, T. and TROWBRIDGE, I.S., p180, a novel recycling transmembrane glycoprotein with restricted cell type expression. Mol. Cell. Biol., 10, 2606-2618 (1990).
15. JACKSON, D.G., BELL, J.I., DICKINSON, R., TIMANS, J., SHIELDS, J. and WHITTLE, N., Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol., 128, 673-685 (1995).
16. JONES, J., SUGIYAMA, M., WATT, F.M. and SPEIGHT, P.M., Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium. J. Pathol., 169, 235-243 (1993).
17. KEEBLE, S. and WATT, F.M., Characterisation of the peanut lectinbinding glycoproteins of human epidermal keratinocytes. Differentiation, 43, 139-145 (1990).
18. KUGELMAN, L.C., GANGULY, S., HAGGERTY, J.G., WEISSMAN, S.M. and MILSTONE, L.M., The core protein of epican, a heparan sulfate proteolgycan on keratinocytes, is an alternative form of CD44. J. Invest. Dermatol., 99, 381-385 (1992).
19. LESLEY, J., HYMAN, R. and KINCADE, P.W., CD44 and its interaction with extracellular matrix. Adv. Immunol., 54, 271-335 (1993).
20. MILSTONE, L.M., HOUGH-MONROE, L., KUGELMAN, L.C., BENDER, J.R. and HAGGERTY, J.G., Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion. J. Cell Sci., 107, 3183-3190 (1994).
21. NICHOLSON, L.J., PEI, X.F. and WATT, F.M., Expression of E-cadherin, P-cadherin and involucrin by normal and neoplastic keratinocytes in culture. Carcinogenesis, 12, 1345-1349 (1991).
22. SALMI, M., GRÖN-VIRTA, K., SOINTU, P., GRENMAN, R., KALIMO, H. and JALKANEN, S., Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J. Cell Biol., 122, 431-442 (1993).
23. SCHROEDER, H.E., Differentiation of human oral stratified epithelia, Karger, Basel (1981).
24. SCREATON, G.R., BELL, M.V., BELL, J.I. and JACKSON, D.G., The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human and rat. J. biol. Chem., 268, 12235-12238 (1993).
25. SCREATON, G.R., BELL, M.V., JACKSON, D.G., CORNELIS, F.B., GERTHE, U. and BELL, J.I., Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. nat. Acad. Sci. (Wash.), 89, 12160-12164 (1992).
26. STAMENKOVIC, I., AMIOT, M., PESANDO, J.M. and SEED, B., A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell, 56, 1057-1062 (1989).
27. STAUDER, R., EISTERER, W., THALER, J. and GÜNTHERT, U., CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood, 85, 2885-2899 (1995).
28. SUMITOMO, S., KUMASA, S., IWAI, Y. and MORI, M., Involucrin expression in epithelial tumors of oral and pharyngeal mucosa and skin. Oral Surg. oral Med. oral Pathol., 62, 155-163 (1986).
29. TAKADA, M., YAMAMOTO, M. and SAITOH, Y., The significance of CD44 in human pancreatic cancer. I. High expression of CD44 in human pancreatic adenocarcinoma. Pancreas, 9, 748-752 (1994).
30. TANABE, K.K., ELLIS, L.M. and SAYA, H., Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 341, 725-726 (1993).
31. TÖLG, C., HOFMANN, M., HERRLICH, P. and PONTA, H., Splicing choice from ten variant exons establishes CD44 variability. Nucl. Acids Res., 21, 1225-1229 (1993).
32. ZÖLLER, M. and KAUFMANN, M., CD44 and metastasis. Onkologie, 17, 114-122 (1994).